Klinische Studie

2023

2023

WHO International Clinical Trials Registry Platform - (2023) vom: 29. Mai Zur Gesamtaufnahme - year:2023

Englisch

Volltext [kostenfrei]

610
Medical Condition: Keratosis pilaris patients in Srinakharinwirot university skin center with lesion on upper outer of arm at the age of 18-50 years old. The patients who enroll the intervention must comply the research regulations and conductions with inform consent process. Exclusion criteria is to qualify in any of the disqualification. For examples; the COVID-19 patient, implantable medical device patient, metal implantable medical device patient, severe heart diseases, active or recent history of malignancy, immune suppression, history of topical retinoid, topical steroid, topical salicylic acid, topical lactic acid, vitamin D analogs in past 4 weeks, history of laser or radiofrequency in past 6 months, history of keratinization drugs such as steroids, Isotretinoin and Acitretin in past 6 months, photosensitivity such as SLE, Connective tissue disease, Autoimmune diseases, history of wax or hair removal procedure on upper arm in past 4 weeks, pregnancy, breastfeeding, psychosis, sunburn or wound and scar in the upper arm Keratosis pilaris, follicular papule, abnormal keratinization, insulated microneedle radiofrequency, needle radiofrequency;Keratosis pilaris, follicular papule, abnormal keratinization, insulated microneedle radiofrequency, needle radiofrequency
Phase: Phase 4
Recruitment Status: Recruiting
Study Type: Interventional

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 12-04-2021, Last updated: 2023-06-05

TCTR20210412005
Nil Known

WHO007598319